What is Encompass Health Corp’s (NYSE:EHC) current market value? Can you beat the fundamentals?

In Thursday’s Wall Street session, Encompass Health Corp (NYSE:EHC) shares traded at $119.04, up 0.13% from the previous session.

EHC stock price is now 0.42% away from the 50-day moving average and 15.47% away from the 200-day moving average. The market capitalization of the company currently stands at $12.00B.

With the price target of $115, KeyBanc Capital Markets recently initiated with Overweight rating for Encompass Health Corp (NYSE: EHC). On July 10, 2024, Leerink Partners recently initiated its ‘Outperform’ rating on the stock quoting a target price of $100, while ‘Barclays’ rates the stock as ‘Overweight’

In other news, Tarr Mark J, President & CEO sold 118,384 shares of the company’s stock on May 20 ’25. The stock was sold for $14,387,152 at an average price of $121.53. Upon completion of the transaction, the President & CEO now directly owns 527,070 shares in the company, valued at $62.74 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 20 ’25, Officer Mark Tarr bought 118,384 shares of the business’s stock. A total of $14,383,656 was incurred on buying the stock at an average price of $121.50. A total of 1.50% of the company’s stock is owned by insiders.

During the past 12 months, Encompass Health Corp has had a low of $82.74 and a high of $123.13. As of last week, the company has a debt-to-equity ratio of 1.25, a current ratio of 1.06, and a quick ratio of 1.06. According to the stock market information, the enterprise value for the company is $15746227200, which is based on a 24.57 price-to-earnings ratio, a 2.17 price-to-earnings-growth ratio, and a beta of 0.89. The fifty day moving average price for EHC is $118.5448 and a two-hundred day moving average price translates $103.091 for the stock.

The latest earnings results from Encompass Health Corp (NYSE: EHC) was released for 2025-03-31. The net profit margin was 8.93% and return on equity was 25.33% for EHC. The company reported revenue of $1.46 billion for the quarter, compared to $1.32 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 10.59 percent. For the current quarter, analysts expect EHC to generate $1.43B in revenue.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.